uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.


WHITE PLAINS, NY, January 31, 2000 — Out of 27 major brands of dietary supplements purporting to contain saw palmetto for treating symptoms of prostate enlargement, only 17 appeared to have ingredients similar to those found in published clinical studies. This is the second major dietary supplement evaluation reported by By year-end, will have tested most of the popular dietary supplements sold in the U.S.

Saw palmetto dietary supplements are primarily used in the U.S. to improve urinary flow and reduce the frequency and urgency of urination in men with prostate enlargement (benign prostatic hyperplasia, or BPH). Saw palmetto and other dietary supplements, which now represent $14 billion in annual sales, are not considered drugs in the U.S. and do not require testing for quality by any governmental or independent agency prior to sale.

Saw palmetto is a type of dwarf palm whose berries are used medicinally, most often in the form of an extract. Among clinically tested saw palmetto extract products, at least 85% of the extract's weight have been attributable to specific fatty acids and sterols. To evaluate products against this standard, purchased 27 leading brands of saw palmetto supplements through retail stores, on-line retailers, and direct sales or multi-level marketing companies. Five saw palmetto extract products were immediately eliminated from testing because their labels indicated that they had been standardized to levels of fatty acids and sterols that were below 85%. A sixth product was eliminated as it had incomplete labeling to determine the amount of saw palmetto per serving.

Among the 21 remaining products that then underwent laboratory analysis, four were found not to contain the minimum amounts of specific fatty acids and/or sterols commonly found in the saw palmetto products used in published clinical trials. These four products all had fatty acid levels that were accordingly too low and two of these products also had inadequate sterol levels. The list of products that passed's independent testing, as well as more information about the testing, are available at

"At a minimum, consumers should be checking the labels of these products to see that they at least purport to contain ingredients shown to work clinically, such as saw palmetto extract standardized to 85% fatty acids and sterols," said Tod Cooperman, M.D., president of "However, as some labels are either incomplete or inaccurate, the names of products that passed's testing are now posted at our Web site," he added. To further assist consumers, is licensing its flask-shaped Seal of Approved Quality for Saw Palmetto to manufacturers and distributors to use on products that have passed testing. will periodically re-evaluate these products to ensure their compliance with its standards. In addition, manufacturers and distributors may request the testing of products not already tested. The list of saw palmetto products that have passed testing will be continually updated.'s Product Reviews this year will include echinacea, calcium, chondroitin, garlic, ginseng, Ginkgo biloba, glucosamine, SAMe, saw palmetto, St. John's wort, vitamin B complex, vitamins C and E, and multivitamins. Product Reviews are being released on a monthly basis at and other Web sites licensed by The next Product Review is to be released later in February and concerns glucosamine and chondroitin products, used primarily to treat conditions associated with osteoarthritis. is an online provider of consumer information and independent evaluations of health, wellness, and nutrition products. The company is privately held and headquartered in White Plains, New York. It is not affiliated with companies that manufacture, distribute, or sell consumer products. Parties interested in licensing content or requesting testing of additional products may contact Lisa Sabin, Vice President for Business Development, at More information about is available at

Copyright, LLC, 2000. All rights reserved. Only for use by news organizations without written permission.

— END —

back to top

Members of the media contact may contact or call the main number (914-722-9149). Please include the name of your news organization when contacting us.